# Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

> **NCT01380457** · PHASE1 · COMPLETED · sponsor: **Par Pharmaceutical, Inc.** · enrollment: 69 (actual)

## Conditions studied

- To Determine Bioequivalence Under Fasting Conditions

## Interventions

- **DRUG:** Dronabinol
- **DRUG:** Marinol

## Key facts

- **NCT ID:** NCT01380457
- **Lead sponsor:** Par Pharmaceutical, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2006-04
- **Final completion:** 2006-04
- **Target enrollment:** 69 (ACTUAL)
- **Last updated:** 2011-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01380457

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01380457, "Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01380457. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*